2007-04-30 to 2007-05-06

Bisphosphonate Lawsuit & News Blog

Bisphosphonate Lawsuits
and Class Actions : Bisphosphonates Blog Home : April 2007 : 2007-04-30 to 2007-05-06

Pharmaceutical company plans to tweak ingredients in Fosamax
April 30, 2007 10:11

Merrion Pharmaceuticals most advanced product is a tweak to the active ingredient in Fosamax, a leader in the multibillion-dollar world of osteoporosis treatments. Fosamax, which is owned by Merck, loses its U.S. patent protection next year.

Initial studies by Merrion show patients better absorb its tweaked version, reducing the required dosage.

Merrion also has potential treatments in the pipeline for bone cancer, prostate cancer, and deep-vein thrombosis. Proceeds from the stock sale will help fund clinical trials for these drugs.

Source: http://www.wilmingtonstar.com/apps/pbcs.dll/article?AID=/20070424/NEWS/704240339/1002

2007-03-19 to 2007-03-25 « » 2007-04-30 to 2007-05-06

© 2008 copyright Anapol Schwartz.
Ask our Lawyers | About Fosamax ONJ | Blog | Site Map | Home |

Disclaimer: Pennsylvania Fosamax Attorney Disclaimer: Fosamax Lawyers, Lawsuits, Class Actions, or other legal information set forth in this site should not be construed to be formal legal advice, nor the formation of a lawyer or attorney client relationship. Please contact a Pennsylvania Osteonecrosis Lawyer at our law firm for information regarding your particular case. This website is not intended to solicit clients outside the States of New Jersey and Pennsylvania.